(Q36689249)

15 August 2017

Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia (English)

1 reference

15 August 2017

Ajay Chavan

1

1 reference

15 August 2017

Lars Luthe

2

1 reference

15 August 2017

Michael Gebel

3

1 reference

15 August 2017

Hannelore Barg-Hock

4

1 reference

15 August 2017

Hans Seifert

5

1 reference

15 August 2017

Rudolph Raab

6

1 reference

15 August 2017

Timm Kirchhoff

7

1 reference

15 August 2017

B Schmuck

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

31 October 2012

1 reference

15 August 2017

1 reference

15 August 2017

23

1 reference

15 August 2017

4

1 reference

15 August 2017

951-957

1 reference

Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Hereditary haemorrhagic telangiectasia: a clinical and scientific review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Liver involvement in hereditary hemorrhagic telangiectasia (HHT).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

Liver transplantation for treatment of intrahepatic Osler's disease: first experiences

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599206

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00330-012-2694-9

Liver disease in patients with hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

12 December 2020

Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia

1 reference

12 December 2020

Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patients

1 reference

12 December 2020

Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab

1 reference

12 December 2020

Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia

1 reference

12 December 2020

10.1007/S00330-012-2694-9

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23111819

1 reference